Cell therapy for atopic dermatitis➜ DOI: 10.1016/j.jaci.2024.06.021Mesenchymal stem cells (MSCs) have been found to play a role in regulating immune responses. Allogenic human bone marrow-derived clonal MSCs (hcMSCs) were administered intravenously weekly for 3 weeks in volunteers with moderate to severe atopic dermatitis (AD) by Korean investigators, with improvement of objective scores at 12 weeks, with [...] Read More
Migayron et al. Front Immunol➜ DOI: 10.3389/fimmu.2024.1405215Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?This is an interesting review which approaches indirectly some of the paradoxical findings observed using targeted therapies in AD. Silverberg et al JAAD➜ DOI: 10.1016/j.jaad.2024.05.023Tapinarof Cream 1% Once Daily: Significant Efficacy in the Treatment of Moderate to Severe Atopic Dermatitis [...] Read More
Carmanius et al, JEADV 2024➜ DOI: 10.1111/jdv.20076A cross-sectional study based on the 24-year follow-up from the population-based birth cohort linked with dispensing data from the National Swedish Drug Register confirms that a large proportion of young adults with AD is undertreated or untreated. Kook et al, JEADV 2024➜ DOI: 10.1111/jdv.20053Misdiagnosis of AD or confounding skin diseases in [...] Read More
Federica Casetti, Cristina Has➜ First published: 03 March 2024 - DOI: 10.1111/ddg.15358Dupilumab improves congenital ichthyosis in the context of a filaggrin pathogenic variant. This report from Germany confirms other reports of a response of rare ichthyotic conditions such as Netherton’s syndrome and trichothiodystrophy to targeting IL-4Rα, and that the common FLG mutations may accentuate the inflammatory phenotype [...] Read More
Docampo-Simon et al Int J Dermatol 2024➜ First published: 03 March 2024 - DOI: 10.1111/ijd.17100Spanish investigators delineate based on a small case series psoriasis dermatitis, a common ambiguous phenotype of early forms of both psoriasis and atopic dermatitis in children; this phenotype was already well recognized in infants, but this study adds arguments for a later [...] Read More
Omatsu et al, Allergol Int 2024➜ PMID: 38310042. - DOI: 10.1016/j.alit.2024.01.008An interesting study from Japan shows that AD is very significantly associated with the incidence of HSV keratitis, and that preexisting AD blepharitis is an important contributing factor.This paper is important in the context of real or supposed AD co-morbidities where ophthalmologic comorbidities are generally not adequately [...] Read More
Watch the recording: Program: Tip: click on the icon on the right to download the presentations. 08:00 am Introduction Therapeutic Patient Education in Poland Moderator: Magdalena TRZECIAK 08:10 am Patient Perspective Joanna MAŁACZYŃSKA RENTFLEISZ (Poland) 08:25 am HCP Perspective Magdalena TRZECIAK (Poland) 08:40 am Roundtable and Q&A AD in Sub-Saharan Africa: The Challenge of a […]
Read More
The deadline for submission is September 30, 2023. Our call is now officially open. This initiative was launched in 2019 by a generous grant of Pfizer with the aim of supporting the training of young dermatologists at a host institution of good standing for AD research. Up to now 8 laureates have completed their stay […]
Read More
The patient-centred pre-meeting “Organization of Care in Atopic Dermatitis” is covering in accordance with the motto of the 13th Georg RAJKA symposium Worldwide Solidarity in the Care of AD Patients. The program has been prepared jointly by Roberto TAKAOKA – who pioneered such initiatives at previous meetings, including virtual symposia held during the COVID pandemic (cf. OCAD meetings […]
Read More
ISAD has received a message from colleagues of the Netherlands asking for help on phototherapy of AD, a “vanishing” field with the development of systemics, to be covered in Gdansk (session 5: Topical treatment and phototherapy: endangered regimens?). They would like to invite experts (dermatologists) on phototherapy for AD to participate in an eDelphi consensus […]
Read More